Children with sickle cell disease show no alarming trends after opioid use
No concerning patterns of long-term or increasing opioid use were observed within 3 years after first opioid prescription in opioid-naive children with SCD.
Identifying arrhythmias in children using smartwatch technology
How effective can wearable technology with features designed for adults be for children when it comes to arrhythmias? Scott Ceresnak, MD, helps provide the answer in this Contemporary Pediatrics interview.
Iron deficiency associated with hearing loss risk in adolescents
Microalbuminuria and low body iron levels displayed a significant association with pediatric hearing loss independently.
Procalcitonin to diagnose pneumonia in children with influenza-like illness
Procalcitonin can be useful for point-of-care testing in patients with influenza-like illness and a prolonged fever, guiding the indication for a chest radiograph while helping to avoid radiation exposure.
Hearing loss prevalence high in children, adults with sickle cell disease
Hearing loss was more prevalent among children and adults with sickle cell disease and its traits compared to matched controls with normal hemoglobin.
Week in review: sNDA for tapinarof cream 1%, psychological interventions for asthma
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
FDA approves omalizumab to reduce allergic reactions in patients with 1 or more food allergies
The approval makes omalizumab the first and only FDA-approved medicine to reduce allergic reactions in patients with one or more food allergies.
Rexlemestrocel-L for children with HLHS receives Orphan-Drug Designation
The Orphan Drug Designation follows the receipt of Rare Pediatric Disease Designation from the FDA in January 2024.
Reaction to tapinarof cream, 1% sNDA submission with Lawrence Eichenfield, MD
Lawrence Eichenfield, MD, highlights the sNDA submission of tapinarof cream, 1% for the topical treatment of atopic dermatitis in children aged 2 years and older.
Experimentation among most common reasons for substance use in adolescence
Promoting mental health and implementing stress-reducing scenarios for adolescents could lessen motivating factors for substance use.
Black youths and females face higher risk for foster care involvement
Results demonstrated that foster care involvement does vary based on age and sex, with Black youths and females disproportionately effected.
Dermavant submits sNDA for tapinarof cream, 1% to treat AD in patients 2 years and up
The sNDA submission follows additional positive topline data that was presented in Janurary 2024, highlighting an open-label, long-term extension study evaluating tapinarof cream, 1%.
Maternal tobacco use tied to late childhood neurocognition deficits
Compared to children with no maternal tobacco usage during pregnancy, those exposed had associations to childhood neurocognition deficits.
A Teen’s Guide to Everything Cancer now in Spanish
Heightened risk of congenital malformations in children born to mothers with asthma
The review and meta-analysis reaffirmed previous data regarding maternal asthma and neonatal outcomes while also uncovering several novel findings.
Psychological interventions for asthma and stress reduction
Discover how recent research unveils the potential of psychological interventions in alleviating asthma attacks and mitigating associated psychological stressors, shedding light on promising avenues for asthma management.
Week in review: Flu recommendation importance, developmental intervention for autism
FDA approves budesonide oral suspension for eosinophilic esophagitis
The twice-daily oral corticosteroid is indicated for 12 weeks of treatment.
Navigating school-based mental health services
Using school-based approaches and staying in close contact with school personnel can increase overall care for the child.
January/February special nutrition issue of Contemporary Pediatrics
Contemporary Pediatrics editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, highlights our special nutrition issue, published for January/February, 2024.
How to help adolescents choose the right contraceptive
Discover effective counseling techniques and overcome barriers to empower adolescents in making informed decisions about contraception, fostering trust, confidentiality, and autonomy in reproductive health care.
Four-year-old with itchy, red, painful hands following snow exposure
The child was otherwise healthy with no prior severe medical issues, and he did not present with COVID-19 symptoms. Can you diagnose this child based on the case below?
Evidence-based developmental interventions for autism
Joshua Feder, MD, explains how developmental care models for autism care can benefit children with autism, providers, parents, and other family members.
Importance of maternal influenza vaccination recommendations
Samantha Olson, MPH, explains the important role of a strong recommendation for maternal influenza vaccination.
Reducing HIV reservoirs in neonates with very early antiretroviral therapy
Deborah Persaud, MD, details results from her study that aimed to reduce HIV reservoirs in neonates with very early antiretroviral therapy.
Clinician poll: Can you diagnose this child with itchy, red, and painful hands?
Read the case and take your best guess at diagnosing this 4-year-old patient.
What determines a healthy weight for a child?
Weight can mean a lot of things. Context is important, and different measurements are used for specific goals.
Maternal influenza vaccination and associated infant hospitalizations
Samantha Olson, MPH, breaks down a study highlighting the effectiveness of maternal influenza vaccination and its respective association with influenza-related hospitalizations in infants.
Study shows increase in STIs in adolescents during the COVID-19 pandemic
Investigators recently noted that despite a decrease in adolescent hospital visits during the height of the pandemic, there was an increase in sexually transmitted infections (STIs) in this population group.
Contemporary Pediatrics week in review: Discussions of tralokinumab and antiretroviral therapy for HIV